Thomas R Kreil

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Monoclonal Antibody

Tyrosine Kinase

Top Venues

Journal of medical virology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Min-Hsin Chen, Ludmila Perelygina, LiJuan Hao, R Suzanne Beard, Cornelia Lackner, Maria R Farcet, Michael Karbiener, Joseph Icenogle, Thomas R Kreil
Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins. The Journal of infectious diseases (2024)
Michael Karbiener, Gerhard Kindle, Isabelle Meyts, Mikko R J Seppänen, Fabio Candotti, Marta Kamieniak, Reinhard Ilk, Thomas R Kreil, Markus G Seidel, null null
Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency. Journal of medical virology 96 (6) (2024)
Michael Karbiener, Gerhard Kindle, Isabelle Meyts, Mikko R J Seppänen, Fabio Candotti, Marta Kamieniak, Reinhard Ilk, Thomas R Kreil, Markus G Seidel, null null
Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency. Journal of medical virology 96 (6) (2024)
Andreas Wieser, Jens Modrof, Thomas R Kreil
Protection of biomanufacturing processes from virus contamination through upstream virus filtration of cell culture media. Biotechnology and bioengineering (2023)
Jean-Baptiste Farcet, Michael Karbiener, Leonhard Zelger, Johanna Kindermann, Thomas R Kreil
Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC. International journal of molecular sciences 24 (9) (2023)
Philippe Pérot, Nicolas Da Rocha, Maria R Farcet, Thomas R Kreil, Marc Eloit
Human Circovirus is not detected in plasma pools for fractionation. Transfusion (2023)
Jean-Baptiste Farcet, Michael Karbiener, Leonhard Zelger, Johanna Kindermann, Thomas R Kreil
Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC. International journal of molecular sciences 24 (9) (2023)
Maria R Farcet, Cornelia Lackner, Andreas Schirmer, Thomas R Kreil
Tetanus antibodies in normal human immunoglobulin preparations. Vox sanguinis (2023)
Johanna Kindermann, Michael Karbiener, Thomas R Kreil
Orthopox viruses and the safety margins of solvent-detergent treated plasma-derived medicinal products. Transfusion 62 (12) (2022)
Michael Karbiener, Maria R Farcet, Andreas Zollner, Taisei Masuda, Mitsuhiro Mori, Alexander R Moschen, Thomas R Kreil
Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines. NPJ vaccines 7 (1) (2022)
Cornelia Lackner, Michael Karbiener, Lukas Faltner, Maria R Farcet, Thomas R Kreil
Feasibility of identifying plasma donors with high measles neutralizing antibody concentrations for the use of producing a measles hyperimmune globulin for postexposure prophylaxis. Immunologic research 70 (3) (2022)
Michael Karbiener, Maria R Farcet, Reinhard Ilk, Jessica Schreiner, James Lenart, Nicholas Powers, Joseph M Stewart, Hema Tallman, Thomas R Kreil
Longitudinal analysis of SARS-CoV-2 antibodies in 8000 U.S. first-time convalescent plasma donations. Transfusion 61 (4) (2021)
Jean-Baptiste Farcet, Johanna Kindermann, Michael Karbiener, Richard Scheinecker, Otto Kostner, Thomas R Kreil
Synthesis of "Nereid," a new phenol-free detergent to replace Triton X-100 in virus inactivation. Journal of medical virology 93 (6) (2020)